Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06721494
PHASE2

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

Sponsor: Clear Scientific, Inc.

View on ClinicalTrials.gov

Summary

The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clinically relevant dose of methamphetamine HCl (30 mg IV).

Official title: A Phase 2 Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants With Methamphetamine Use Disorder Not Seeking Treatment Receiving a Single Dose of Methamphetamine

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-02-05

Completion Date

2026-09-11

Last Updated

2026-01-12

Healthy Volunteers

No

Interventions

DRUG

Methamphetamine

Methamphetamine HCl for intravenous administration

DRUG

Sterile Saline

Sterile Saline for intravenous administration

DRUG

CS-1103

CS-1103 for intravenous administration

Locations (1)

California Clinical Trials Medical Group

Glendale, California, United States